Plethora Solutions Ltd   Report issue

For profit Phase 1 Phase 3
Founded: Chalgrove United Kingdom (2003)
Status: Left NME R&D (2013)

Organization Overview

First Clinical Trial
2007
NCT00483990
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Plethora Solutions Ltd

Active Ingredients

Drugs in Phase 3 Trials (2)

lidocaine (xylocaine) (5 trials)

prilocaine (citanest) (4 trials)

Drugs in Phase 1 Trials (3)

fosamprenavir (lexiva) (1 trial)

ritonavir (Norvir) (1 trial)

secukinumab (cosentyx) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Premature Birth (Phase 3)

Premature Ejaculation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5